<DOC>
	<DOCNO>NCT00237263</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy long-term treatment entacapone patient Parkinson 's disease end-of-dose wearing-off . This study recruit patient United States .</brief_summary>
	<brief_title>An Extension Study Entacapone Patients With Parkinson 's Disease With End-of-dose Wearing-off . This Study Not Recruiting United States</brief_title>
	<detailed_description>The purpose study evaluate safety efficacy long-term treatment entacapone patient Parkinson 's disease end-of-dose wearing-off .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Entacapone</mesh_term>
	<criteria>Attended Phase IIb study Able fill patient diary Serious heart , pulmonary , renal , hepatic gastrointestinal disease Dementia symptoms Pregnant nursing ( lactate ) woman Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Parkinson 's disease , end-of -dose wearing-off , entacapone</keyword>
</DOC>